Cyclic Peptidic Furin Inhibitors Developed by Combinatorial Chemistry
Agata Gitlin‐Domagalska, Dawid Dębowski, Aleksandra Maciejewska, Sergey A. Samsonov, Martyna Maszota‐Zieleniak, Natalia Ptaszyńska, Anna Łęgowska, Krzysztof Rolka
Abstract
High Resolution Image Download MS PowerPoint Slide Furin is a human serine protease responsible for activating numerous physiologically relevant cell substrates and is also involved in the development of various pathological conditions, including inflammatory diseases, cancers, and viral and bacterial infections. Therefore, compounds with the ability to inhibit furin’s proteolytic action are regarded as potential therapeutics. Here we took the combinatorial chemistry approach (library consisting of 2000 peptides) to obtain new, strong, and stable peptide furin inhibitors. The extensively studied trypsin inhibitor SFTI-1 was used as a leading structure. A selected monocylic inhibitor was further modified to finally yield five mono- or bicyclic furin inhibitors with values of K i in the subnanomolar range. Inhibitor 5 was the most active ( K i = 0.21 nM) and significantly more proteolytically resistant than the reference furin inhibitor described in the literature. Moreover, it reduced furin-like activity in PANC-1 cell lysate. Detailed analysis of furin–inhibitor complexes using molecular dynamics simulations is also reported.